Author: Robert Truog

From Single-Task to Multi-Condition: Radiology AI Grows Up
The FDA's clearance of Aidoc's multi-condition CT triage platform marks a pivotal shift from narrow, single-purpose AI tools
Healthcare AI Matures from Experiment to Essential
OpenEvidence's $12 billion valuation and the Gates Foundation's Horizon1000 partnership with OpenAI mark a turning point for healthcare
Healthcare AI's Governance Gap: Promise Meets Policy
As healthcare AI deployment accelerates nationwide, a critical governance gap is emerging. This analysis examines the tension between
AI Comes to African Clinics: Horizon 1000's Promise
The Gates Foundation and OpenAI's $50 million Horizon 1000 initiative aims to deploy AI diagnostic tools to 1,000
Healthcare AI's Scaling Problem: Data and Disparities
Healthcare's AI ambitions are colliding with practical realities. With 62% of leaders citing fragmented data as their primary
Healthcare AI Reaches Its Tipping Point in 2026
After years of cautious skepticism, physicians and healthcare leaders are reaching consensus: AI's benefits in clinical settings now
Big Pharma Meets Big Tech in Oncology AI
The Bristol Myers Squibb-Microsoft collaboration to develop AI-powered lung cancer detection tools signals a fundamental shift in pharmaceutical
AI Giants Battle for Healthcare's Future
OpenAI and Anthropic have launched competing healthcare AI products—ChatGPT Health and Claude for Healthcare—marking a strategic battle for
Healthcare Leaders Unite: AI Adoption Is Non-Negotiable
Healthcare's most prominent voices are converging on a striking consensus: AI adoption is essential for system survival. From
AI Medical Imaging Matures Beyond Hype to Value
The AI medical imaging market is transitioning from experimental deployments to an $8.5+ billion industry by 2030. With

We’ll get back to you shortly

By submitting your information you agree to PhysEmp’s Privacy Policy and Terms of Use…